Ignite Creation Date:
2024-05-06 @ 1:51 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01911273
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2013-07-26
Brief Title:
A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 A Monoclonal Antibody With Antiangiogenic Features In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer
Sponsor:
Pfizer
Organization:
Pfizer